Designed Extension of Studies Based on Conditional Power

DOI10.2307/2533262zbMath0875.62506OpenAlexW1986502618WikidataQ70971455 ScholiaQ70971455MaRDI QIDQ4335625

Michael A. Proschan, Sally A. Hunsberger

Publication date: 9 November 1997

Published in: Biometrics (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.2307/2533262

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10) Parametric hypothesis testing (62F03)

Related Items (69)

Benefit–Risk Evaluation of Multi-Stage Adaptive Designs ⋮ The Influence of Biostatistics at the National Heart, Lung, and Blood Institute ⋮ Optimal Conditional Error Functions for the Control of Conditional Power ⋮ Estimation of a Parameter and Its Exact Confidence Interval Following Sequential Sample Size Reestimation Trials ⋮ Novel Bayesian Adaptive Designs and Their Applications in Cancer Clinical Trials ⋮ Longitudinal clinical trials with adaptive choice of follow‐up time ⋮ An evaluation of inferential procedures for adaptive clinical trial designs with pre-specified rules for modifying the sample size ⋮ A note on the shape of sample size functions of optimal adaptive two-stage designs ⋮ Unnamed Item ⋮ Methodology and application of adaptive and sequential approaches in contemporary clinical trials ⋮ Optimization of adaptive designs with respect to a performance score ⋮ A comparison between two treatments in a clinical trial with an ethical allocation design ⋮ Asymptotic properties of maximum likelihood estimators with sample size recalculation ⋮ Single-arm phase II three-outcome designs with handling of over-running/under-running ⋮ Generalized Likelihood Ratio Statistics and Uncertainty Adjustments in Efficient Adaptive Design of Clinical Trials ⋮ Adaptive Design and Estimation in Randomized Clinical Trials with Correlated Observations ⋮ Improving the Flexibility and Efficiency of Phase II Designs for Oncology Trials ⋮ Optimal two-stage group-sequential designs ⋮ Interim Design Modifications in Time-to-Event Studies ⋮ Probabilistic Foundation of Confirmatory Adaptive Designs ⋮ Development of Adaptive Group Sequential Procedure for Changing Sample Size ⋮ Robustness of sample size re-estimation with interim binary data for double-blind clinical trials ⋮ Modification of Sample Size in Group Sequential Clinical Trials ⋮ Adaptive Sample Size Calculations in Group Sequential Trials ⋮ Interim Analysis and Sample Size Reassessment ⋮ On the efficiency of adaptive designs for flexible interim decisions in clinical trials ⋮ On design and inference for two-stage adaptive clinical trials with dependent data ⋮ Internal pilots for observational studies ⋮ Data-Driven Analysis Strategies for Proportion Studies in Adaptive Group Sequential Test Designs ⋮ Sample size reassessment for a two-stage design controlling the false discovery rate ⋮ Sequential Methods in Multi-Arm Clinical Trials ⋮ Blinded sample size recalculation in adaptive enrichment designs ⋮ p-Value calculation for multi-stage additive tests ⋮ A covariate-adjusted adaptive design for two-stage clinical trials with survival data ⋮ Analysis of ``learn-as-you-go (LAGO) studies ⋮ Discussion on “Second-Guessing Clinical Trial Designs” by Jonathan J. Shuster and Myron N. Chang ⋮ Two-stage randomized clinical trials with a right-censored endpoint: comparison of frequentist and Bayesian adaptive designs ⋮ Adding experimental treatment arms to multi-arm multi-stage platform trials in progress ⋮ A multi-arm multi-stage platform design that allows preplanned addition of arms while still controlling the family-wise error ⋮ Point estimation, confidence intervals, and \(P\)-values for optimal adaptive two-stage designs with normal endpoints ⋮ Sample size adaptation designs and efficiency comparison with group sequential designs ⋮ Monitoring Continuous Long-Term Outcomes in Adaptive Designs ⋮ A variational approach to optimal two-stage designs ⋮ Conditional power and friends: the why and how of (un)planned, unblinded sample size recalculations in confirmatory trials ⋮ Sample size re-estimation for covariate-adaptive randomized clinical trials ⋮ Optimal planning of adaptive two-stage designs ⋮ Optimal adaptive promising zone designs ⋮ An additive boundary for group sequential designs with connection to conditional error ⋮ Bayesian two-stage adaptive design in bioequivalence ⋮ Confirmatory adaptive designs for clinical trials with multiple time-to-event outcomes in multi-state Markov models ⋮ On Sample Size and Inference for Two‐Stage Adaptive Designs ⋮ Adaptive Group Sequential Designs for Clinical Trials: Combining the Advantages of Adaptive and of Classical Group Sequential Approaches ⋮ Monitoring Clinical Trials with Multiple Arms ⋮ Self-Designing Two-Stage Trials to Minimize Expected Costs ⋮ Group sequential designs for clinical trials when the maximum sample size is uncertain ⋮ New results on optimal conditional error functions for adaptive two-stage designs ⋮ A Bayesian adaptive design for two-stage clinical trials with survival data ⋮ Inference of non-centrality parameter of a truncated non-central chi-squared distribution ⋮ Adaptive Multivariate Global Testing ⋮ Exact Confidence Bounds Following Adaptive Group Sequential Tests ⋮ Procedures for testing multiple endpoints in clinical trials: an overview ⋮ An Approach to the Conditional Error Rate Principle with Nuisance Parameters ⋮ Basic concepts of group sequential and adaptive group sequential test procedures ⋮ Optimal adaptive two-stage designs for phase II cancer clinical trials ⋮ Adaptive Design for Censored Survival Data Adjusting for Covariates ⋮ Are Flexible Designs Sound? ⋮ THE ATTRACTIVENESS OF THE CONCEPT OF A PROSPECTIVELY DESIGNED TWO-STAGE CLINICAL TRIAL ⋮ ESTIMATION FOLLOWING EXTENSION OF A STUDY ON THE BASIS OF CONDITIONAL POWER ⋮ Maximum type 1 error rate inflation in multiarmed clinical trials with adaptive interim sample size modifications

This page was built for publication: Designed Extension of Studies Based on Conditional Power